CN Bio, iiCON enter deal to advance COVID-19 research

2021-11-16

The Infection Innovation Consortium and CN Bio are collaborating on the validation of more advanced COVID-19 research tools, particularly organ-on-a-chip technology. "[T]he data generated will be published, providing us with proof that supports the adoption of PhysioMimix microphysiological systems into industry, where they can be used as translational tools to accelerate understanding of SARS-CoV-2 infection and consequently, accelerate the development of new therapeutic options," said Tomasz Kostrzewski, director of biology at CN Bio.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.